HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Flashglucose monitoring system (Freestyle Libre, Abbott), report updated April 8 2020]
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Testing for clostridium difficile in oncology patients
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Securement of Arterial Catheters
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Guidance for Prostate Cancer Screening
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Risk Factors for Surgical Site Infection and Infection Prevention in Elective Spine Surgery
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Venous Thromboembolism Prevention for Obese Patients
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Scales for Assessing Patients Receiving Moderate Sedation
2018	Penn Medicine Center for Evidence-based Practice (CEP)	The Effect of Electronic Medical Record Alerts on Provider Wellness
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: antibiotic prophylaxis during clean orthopedic surgery in children and adults]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge on organizational models for intensive care units]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: national and international practices in the organization of rehabilitative care for adults with permanent or temporary motor disabilities]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: living environment quality in long-term care facilities for dependent seniors]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: regulation of private congregate living facilities for the elderly]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: ministerial standards of access, quality, continuity, efficiency and effectiveness of the service d’intervention de crise dans le milieu 24/7]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: herpes simplex eye disease]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: blepharitis]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: islet transplantation in patients with unstable type I diabetes]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: portrait of opioid use in persons covered by Québec’s public prescription drug insurance plan]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the use of EndoPredict and Prosigna for early invasive breast cancer]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: equitable access to the psychotherapy services in Quebec]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: a profile of the practices adopted in Quebec to facilitate the transition to adulthood of young people who reside in an alternative living facility]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: strategies to optimize the appropriateness of MRI and CT requests - strategies and tools for optimal use]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: surgical treatment of the esophagus - quality and accessibility in Quebec]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mild traumatic brain injury, knowledge update in preparation for the revision of the ministerial orientations for mild traumatic brain injury (2005-2010)]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice in pediatric trauma care: patients admitted to the designated facilities of the trauma care network between 2010 and 2015]
2018	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of clinical data from electronic medical records for research and continuous quality improvement in front-line care and services]
2018	European Network for Health Technology Assessment (EUnetHTA)	Alectinib (Alecensa©) as monotherapy for the first line treatment of adult patients with ALK-positive advanced non-small cell lung cancer (NSCLC)
2018	European Network for Health Technology Assessment (EUnetHTA)	Screening of fetal trisomies 21, 18 and 13 by non invasive prenatal testing
2018	European Network for Health Technology Assessment (EUnetHTA)	MammaPrint® – added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer
2018	European Network for Health Technology Assessment (EUnetHTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2018	European Network for Health Technology Assessment (EUnetHTA)	Femtosecond laser-assisted cataract surgery (FLACS) for the treatment of age-related cataract
2018	European Network for Health Technology Assessment (EUnetHTA)	Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin
2018	European Network for Health Technology Assessment (EUnetHTA)	High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer
2018	European Network for Health Technology Assessment (EUnetHTA)	Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nusinersen in spinal muscular atrophy]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Phlebotonics for venous insufficiency]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endometrial receptivity array in assisted reproduction]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[High altitude simulation test for patients with lung disease]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Radiofrequency percutaneous nucleoplasty in disc disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thioridazine for the treatment of behavior disorders in patients with intellectual disability]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pomalidomide combined with dexamethasone in multiple myeloma]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Fetoscopic laser photocoagulation in twin-twin transfusion syndrome]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Daratumumab for relapsed or refractory multiple myeloma]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Rotigotine for Parkinson’s disease]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endovascular thrombectomy in acute ischemic stroke]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Atezolizumab in non-small cell lung cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ramucirumab for advanced gastric or gastroesophageal junction cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Anti-d immunoglobulin in pregnancy and immune thrombocytopenia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lacosamide in epilepsy]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin in adult patients with dystonia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Uvulopalatopharyngoplasty for snoring and obstructive sleep apnea]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Extended adjuvant endocrine therapy in breast cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dynamic magnetic resonance imaging for focal liver lesion assessment]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nabiximols for spasticity and chronic pain]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Extracorporeal shock wave therapy in musculoskeletal disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Genetic testing in primary dystonia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Prompt therapy in patients with speech disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Global postural re-education (RPG®) in spine conditions]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Gait laboratory in patients with gait disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Riluzole in amyotrophic lateral sclerosis]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Alemtuzumab in multiple sclerosis]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunoglobulin in chronic inflammatory demyelinating polyneuropathy and other neurological conditions]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunoglobulin for myasthenia gravis chronic treatment]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[PET/CT scan for solitary pulmonary nodule and non-small cell lung cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[LDL-Apheresis in familial hypercholesterolemia and hypertriglyceridemia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Abemaciclib, palbociclib and ribociclib in breast cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[T2 mapping for articular cartilage assessment]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pyridostigmine with aminopyridines in myasthenia gravis or Lambert-Eaton myasthenic syndrome]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Natalizumab for recurrent-remitting and JC virus seropositive multiple sclerosis]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Argon plasma coagulation for gastrointestinal lesions]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Procalcitonin-guided antibiotic therapy for acute infections]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Venetoclax for relapsed or refractory chronic lymphocytic leukemia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Trastuzumab emtansine for breast cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Stereotactic body radiotherapy in liver tumors]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Stereotactic body radiotherapy for prostate cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Continuous subcutaneous infusion pump for diabetic patients]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Stereotactic body radiotherapy for lung cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Hydrotherapy in skeletal muscle disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dynamic stabilization with interspinous devices for spinal conditions]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Neuronavigator-guided brain neurosurgical procedures]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Music therapy in children with developmental disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Narrow band imaging (NBI) in diagnostic gastrointestinal endoscopy]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Hormone receptor testing in breast cancer]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vancomycin trough for therapeutic monitoring]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Biofeedback in adults with fecal and/or urinary incontinence]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vertebroplasty or kyphoplasty in osteoporotic vertebral fractures]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Trabecular micro bypass stent for glaucoma]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lumacaftor/Ivacaftor therapy in cystic fibrosis]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cognitive rehabilitation in secondary cognitive impairment]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Scalp cooling in patients at risk of chemotherapy-induced alopecia]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Negative-pressure wound therapy for chronic wounds]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vitamin D - population screening and supplementation in populations with deficit]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Negative-pressure wound therapy]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron emission tomography (pet) for routine follow-up of selected neoplasms]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Rituximab for patients with diagnosed chronic neuromyelitis, myasthenia gravis and chronic inflammatory demyelinating polyneuropathy]